Tags
- Abbott
- Abcodia
- Accium BioSciences
- Activiomics
- addiction
- ADHD
- adrenal cancer
- Advanced Biomarker Technologies
- alcohol abuse
- allergies
- Alzheimer's
- amyotrophic lateral sclerosis
- anemia
- animal testing
- Arsenic
- asthma
- Asuragen
- athletes
- autism
- Avantra
- Avastin
- Avid Radiopharmaceuticals
- babies
- Bak
- Banyan Biomarkers
- Bayer
- BG Medicine
- BGI
- Biogen Idec
- biomarker deals
- biomarker discovery
- Biomarker growth
- biomarker industry
- Biomarker R&D
- biomarker venture capital
- Biomarkers
- Biomarkers Consortium
- Biosensors
- bipolar disorder
- birth risk
- bladder cancer biomarkers
- blood test
- Boston Scientific
- Brain injuries
- Brain Resource
- brain tumor biomarker
- BRCA1
- breast cancer
- Breast cancer biomarker
- breath test
- Bristol-Myers Squibb
- Caliper Life Sciences
- cancer
- cancer biomarker
- Cellular Dynamics International
- Ceres Nanosciences
- China
- chronic fatigue syndrome
- chronic kidney disease
- Cleveland Clinic
- clinical trial
- colon cancer
- colorectal cancer
- companion diagnostics
- concussions
- Congress
- contaminated water
- COPD
- Copeptin
- Coronary artery disease
- Courtagen Life Science
- Creutzfeldt-Jakob disease
- Crohn's disease
- CRP
- Dana-Farber Cancer Institute
- dementia
- depression
- Diabetes biomarker
- diagnostics
- DNA
- Drug discovery
- ectopic pregnancy
- Eli Lilly
- epilepsy
- Erbitux
- esophageal cancer
- estrogen
- Europe
- Exiqon
- Exonhit Therapeutics
- Ezose Sciences
- FDA
- Febit
- fetal alcohol syndrome
- FGF23
- Fred Hutchinson Cancer Research Center
- Fujirebio Diagnostics
- gastrointestinal bacteria
- GeneNews Limited
- Genentech
- genetic markers
- Genomic Health
- GenWay Biotech
- Glioblastoma
- GnuBio
- graft-versus-host disease
- hair
- head and neck cancer
- HealthLinx
- heart disease biomarkers
- HeartLab
- Hepatits C
- HistoRx
- HIV
- HLA molecules
- human-growth hormone
- Huntington's
- Icon
- imaging biomarkers
- inflammation
- Japan
- Jinfiniti Biosciences
- Johns Hopkins
- Johnson & Johnson
- King Saud University
- Lead poisoning
- leukemia
- lipid biomarkers
- London Genetics
- Lumacan
- lung cancer
- lung damage biomarker
- lupus
- Lupus nephritis
- Lyme disease
- MabCure
- macrosomia
- Mass spectrometry
- Massachusetts
- MD Anderson Cancer Center
- MDxHealth
- measles
- Medco
- melanoma
- mental illness biomarkers
- Merck
- Merck KGaA
- Metabolon
- Metamark
- Michael J. Fox Foundation
- microneedles
- micropatch
- microsponge
- miRNA
- Mount Sinai
- multiple sclerosis
- Myriad Genetics
- nanoparticles
- NanoSponges
- National Cancer Institute
- National Institutes of Health
- NeoProteomics
- neuroendocrine cancers
- nonlipid biomarkers
- Novartis
- Nuclea Biotechnologies
- nutrition biomarkers
- obesity
- OncoSec
- ovarian cancer biomarker
- Oxford Gene Technology
- Pacific Biomarkers
- pancreatic cancer
- Parkinson's
- Pathwork Diagnostics
- Paul Broca
- PCA3 gene
- pediatric biomarkers
- peptoids
- peripheral artery disease
- personalized medicine
- Pfizer
- Photocure
- PI3K
- Predictive Biosciences
- preeclampsia
- PrognosDx Health
- Promega
- prostate cancer
- Protagen
- protein biomarker
- proteins
- Proteome Sciences
- Proteomics
- PSA
- psychological disorders
- PTSD
- Qiagen
- Quanterix
- Quintiles
- radiation
- renin
- Repligen
- resveratrol
- RG3039
- Ridge Diagnostics
- Roche
- Rosetta Genomics
- Rules-Based Medicine
- safety biomarkers
- saliva biomarkers
- Salix Pharmaceuticals
- Saudi Arabia
- schizophrenia
- sclerostin
- sepsis
- Sera Prognostics
- Serametrix
- serious adverse events
- Siena Biotech
- Sirius Genomics
- smoking cessation
- spinal muscular atrophy
- stomach cancer
- stress biomarkers
- stroke
- SureGene
- systems biology
- Takeda Pharmaceuticals
- tamoxifen
- telatinib
- telomeres
- Tethys Bioscience
- Thermo Fisher
- thyroid cancer
- tivozanib
- toxicity biomarkers
- Transgenomic
- traumatic brain injury
- tuberculosis
- type 1 diabetes
- type 2 diabetes
- UCSF
- University of Oklahoma
- Vermillion
- weight loss
- Zinfandel Pharmaceuticals
